Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode, our editor-in-chief Taissa Vila sits down with Dr. Beatriz Grinsztejn to discuss the challenges of expanding access to pre-exposure prophylaxis (PrEP), with a focus on issues of adherence and equity in Latin America.
We explore the potential of Lenacapavir as a game-changing intervention, reflect on lessons learned from previous experiences with injectable PrEP, and examine the critical importance of introducing new prevention tools through an equity-based approach.
Finally, we look ahead to what Lenacapavir could mean for the future of HIV prevention strategies worldwide. Tune in for an insightful conversation on how innovative strategies like Lenacapavir could reshape the future of HIV awareness and prevention.
Read the full article:
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00156-5/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laname